Global Fluorinated Pharmaceutical Intermediates Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 113

Published Date: 29 Aug 2022

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Fluorine-containing intermediates are chemical raw materials or chemical products used in the process of drug synthesis. Such chemical products can be produced in ordinary chemical plants without a drug production license. Can be used for the synthesis of drugs.

The Fluorinated Pharmaceutical Intermediates market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Fluorinated Pharmaceutical Intermediates market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Fluorinated Pharmaceutical Intermediates market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Antiviral Drug occupied for % of the Fluorinated Pharmaceutical Intermediates global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Aromatic Fluoride segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Fluorinated Pharmaceutical Intermediates include Lonza, Catalent, Patheon, BASF and Jubilant, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Fluorinated Pharmaceutical Intermediates market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.

Main Fluorinated Pharmaceutical Intermediates companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Fluorinated Pharmaceutical Intermediates market based on the following parameters – headquarters, products portfolio, Fluorinated Pharmaceutical Intermediates revenue and gross margin, recent developments.

Evaluation and forecast the Fluorinated Pharmaceutical Intermediates market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Fluorinated Pharmaceutical Intermediates market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type (2017-2028; USD Million)
    Aromatic Fluoride
    Aliphatic Fluoride

Market segment by Application (2017-2028; USD Million)
    Antiviral Drug
    Anti-infectives Drug
    Antirheumatic Drug
    Antibacterial Drug
    Others

The key market players for global Fluorinated Pharmaceutical Intermediates market are listed below:
    Lonza
    Catalent
    Patheon
    BASF
    Jubilant
    Granules
    Ganesh
    Chemcon
    Chemours
    Zhejiang Yongtai Technology
    Shenzhen Capchem Technology
    Zhejiang Zhongxin Fluoride Materials
    Jiangsu Feiyu Technology
    Shanghai Sinofluoro
    Shanghai Aqbiopharma
    Hangzhou Fluoro Pharmaceutical
    Zhejiang Dayang Biotech
    Shandong Feiyuan Group

Region Segment (2017-2028; USD Million)
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
    South America (Brazil, Argentina, Colombia and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Fluorinated Pharmaceutical Intermediates product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Fluorinated Pharmaceutical Intermediates, with revenue, gross margin and global market share of Fluorinated Pharmaceutical Intermediates from 2019 to 2022.
Chapter 3, the Fluorinated Pharmaceutical Intermediates competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Fluorinated Pharmaceutical Intermediates market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Fluorinated Pharmaceutical Intermediates research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Fluorinated Pharmaceutical Intermediates
    1.2 Classification of Fluorinated Pharmaceutical Intermediates by Type
        1.2.1 Overview: Global Fluorinated Pharmaceutical Intermediates Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type in 2021
        1.2.3 Aromatic Fluoride
        1.2.4 Aliphatic Fluoride
    1.3 Global Fluorinated Pharmaceutical Intermediates Market by Application
        1.3.1 Overview: Global Fluorinated Pharmaceutical Intermediates Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Antiviral Drug
        1.3.3 Anti-infectives Drug
        1.3.4 Antirheumatic Drug
        1.3.5 Antibacterial Drug
        1.3.6 Others
    1.4 Global Fluorinated Pharmaceutical Intermediates Market Size & Forecast
    1.5 Global Fluorinated Pharmaceutical Intermediates Market Size and Forecast by Region
        1.5.1 Global Fluorinated Pharmaceutical Intermediates Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Fluorinated Pharmaceutical Intermediates Market Size by Region, (2017-2022)
        1.5.3 North America Fluorinated Pharmaceutical Intermediates Market Size and Prospect (2017-2028)
        1.5.4 Europe Fluorinated Pharmaceutical Intermediates Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size and Prospect (2017-2028)
        1.5.6 South America Fluorinated Pharmaceutical Intermediates Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Fluorinated Pharmaceutical Intermediates Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Fluorinated Pharmaceutical Intermediates Market Drivers
        1.6.2 Fluorinated Pharmaceutical Intermediates Market Restraints
        1.6.3 Fluorinated Pharmaceutical Intermediates Trends Analysis

2 Company Profiles
    2.1 Lonza
        2.1.1 Lonza Details
        2.1.2 Lonza Major Business
        2.1.3 Lonza Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.1.4 Lonza Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Lonza Recent Developments and Future Plans
    2.2 Catalent
        2.2.1 Catalent Details
        2.2.2 Catalent Major Business
        2.2.3 Catalent Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.2.4 Catalent Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Catalent Recent Developments and Future Plans
    2.3 Patheon
        2.3.1 Patheon Details
        2.3.2 Patheon Major Business
        2.3.3 Patheon Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.3.4 Patheon Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Patheon Recent Developments and Future Plans
    2.4 BASF
        2.4.1 BASF Details
        2.4.2 BASF Major Business
        2.4.3 BASF Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.4.4 BASF Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 BASF Recent Developments and Future Plans
    2.5 Jubilant
        2.5.1 Jubilant Details
        2.5.2 Jubilant Major Business
        2.5.3 Jubilant Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.5.4 Jubilant Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Jubilant Recent Developments and Future Plans
    2.6 Granules
        2.6.1 Granules Details
        2.6.2 Granules Major Business
        2.6.3 Granules Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.6.4 Granules Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Granules Recent Developments and Future Plans
    2.7 Ganesh
        2.7.1 Ganesh Details
        2.7.2 Ganesh Major Business
        2.7.3 Ganesh Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.7.4 Ganesh Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Ganesh Recent Developments and Future Plans
    2.8 Chemcon
        2.8.1 Chemcon Details
        2.8.2 Chemcon Major Business
        2.8.3 Chemcon Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.8.4 Chemcon Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Chemcon Recent Developments and Future Plans
    2.9 Chemours
        2.9.1 Chemours Details
        2.9.2 Chemours Major Business
        2.9.3 Chemours Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.9.4 Chemours Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Chemours Recent Developments and Future Plans
    2.10 Zhejiang Yongtai Technology
        2.10.1 Zhejiang Yongtai Technology Details
        2.10.2 Zhejiang Yongtai Technology Major Business
        2.10.3 Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.10.4 Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Zhejiang Yongtai Technology Recent Developments and Future Plans
    2.11 Shenzhen Capchem Technology
        2.11.1 Shenzhen Capchem Technology Details
        2.11.2 Shenzhen Capchem Technology Major Business
        2.11.3 Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.11.4 Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Shenzhen Capchem Technology Recent Developments and Future Plans
    2.12 Zhejiang Zhongxin Fluoride Materials
        2.12.1 Zhejiang Zhongxin Fluoride Materials Details
        2.12.2 Zhejiang Zhongxin Fluoride Materials Major Business
        2.12.3 Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.12.4 Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Zhejiang Zhongxin Fluoride Materials Recent Developments and Future Plans
    2.13 Jiangsu Feiyu Technology
        2.13.1 Jiangsu Feiyu Technology Details
        2.13.2 Jiangsu Feiyu Technology Major Business
        2.13.3 Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.13.4 Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Jiangsu Feiyu Technology Recent Developments and Future Plans
    2.14 Shanghai Sinofluoro
        2.14.1 Shanghai Sinofluoro Details
        2.14.2 Shanghai Sinofluoro Major Business
        2.14.3 Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.14.4 Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Shanghai Sinofluoro Recent Developments and Future Plans
    2.15 Shanghai Aqbiopharma
        2.15.1 Shanghai Aqbiopharma Details
        2.15.2 Shanghai Aqbiopharma Major Business
        2.15.3 Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.15.4 Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Shanghai Aqbiopharma Recent Developments and Future Plans
    2.16 Hangzhou Fluoro Pharmaceutical
        2.16.1 Hangzhou Fluoro Pharmaceutical Details
        2.16.2 Hangzhou Fluoro Pharmaceutical Major Business
        2.16.3 Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.16.4 Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Hangzhou Fluoro Pharmaceutical Recent Developments and Future Plans
    2.17 Zhejiang Dayang Biotech
        2.17.1 Zhejiang Dayang Biotech Details
        2.17.2 Zhejiang Dayang Biotech Major Business
        2.17.3 Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.17.4 Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Zhejiang Dayang Biotech Recent Developments and Future Plans
    2.18 Shandong Feiyuan Group
        2.18.1 Shandong Feiyuan Group Details
        2.18.2 Shandong Feiyuan Group Major Business
        2.18.3 Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Product and Solutions
        2.18.4 Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 Shandong Feiyuan Group Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Fluorinated Pharmaceutical Intermediates Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Fluorinated Pharmaceutical Intermediates Players Market Share in 2021
        3.2.2 Top 10 Fluorinated Pharmaceutical Intermediates Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Fluorinated Pharmaceutical Intermediates Players Head Office, Products and Services Provided
    3.4 Fluorinated Pharmaceutical Intermediates Mergers & Acquisitions
    3.5 Fluorinated Pharmaceutical Intermediates New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Fluorinated Pharmaceutical Intermediates Revenue and Market Share by Type (2017-2022)
    4.2 Global Fluorinated Pharmaceutical Intermediates Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Application (2017-2022)
    5.2 Global Fluorinated Pharmaceutical Intermediates Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2028)
    6.2 North America Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2028)
    6.3 North America Fluorinated Pharmaceutical Intermediates Market Size by Country
        6.3.1 North America Fluorinated Pharmaceutical Intermediates Revenue by Country (2017-2028)
        6.3.2 United States Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        6.3.3 Canada Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        6.3.4 Mexico Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2028)
    7.2 Europe Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2028)
    7.3 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country
        7.3.1 Europe Fluorinated Pharmaceutical Intermediates Revenue by Country (2017-2028)
        7.3.2 Germany Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        7.3.3 France Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        7.3.5 Russia Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        7.3.6 Italy Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2028)
    8.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2028)
    8.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region
        8.3.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue by Region (2017-2028)
        8.3.2 China Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        8.3.3 Japan Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        8.3.4 South Korea Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        8.3.5 India Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        8.3.7 Australia Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2028)
    9.2 South America Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2028)
    9.3 South America Fluorinated Pharmaceutical Intermediates Market Size by Country
        9.3.1 South America Fluorinated Pharmaceutical Intermediates Revenue by Country (2017-2028)
        9.3.2 Brazil Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        9.3.3 Argentina Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2028)
    10.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2028)
    10.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country
        10.3.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Revenue by Country (2017-2028)
        10.3.2 Turkey Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)
        10.3.4 UAE Fluorinated Pharmaceutical Intermediates Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Fluorinated Pharmaceutical Intermediates Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Fluorinated Pharmaceutical Intermediates Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Fluorinated Pharmaceutical Intermediates Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Fluorinated Pharmaceutical Intermediates Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Region (2023-2028)
    Table 6. Lonza Corporate Information, Head Office, and Major Competitors
    Table 7. Lonza Major Business
    Table 8. Lonza Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 9. Lonza Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Catalent Corporate Information, Head Office, and Major Competitors
    Table 11. Catalent Major Business
    Table 12. Catalent Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 13. Catalent Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Patheon Corporate Information, Head Office, and Major Competitors
    Table 15. Patheon Major Business
    Table 16. Patheon Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 17. Patheon Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. BASF Corporate Information, Head Office, and Major Competitors
    Table 19. BASF Major Business
    Table 20. BASF Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 21. BASF Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Jubilant Corporate Information, Head Office, and Major Competitors
    Table 23. Jubilant Major Business
    Table 24. Jubilant Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 25. Jubilant Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Granules Corporate Information, Head Office, and Major Competitors
    Table 27. Granules Major Business
    Table 28. Granules Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 29. Granules Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Ganesh Corporate Information, Head Office, and Major Competitors
    Table 31. Ganesh Major Business
    Table 32. Ganesh Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 33. Ganesh Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Chemcon Corporate Information, Head Office, and Major Competitors
    Table 35. Chemcon Major Business
    Table 36. Chemcon Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 37. Chemcon Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Chemours Corporate Information, Head Office, and Major Competitors
    Table 39. Chemours Major Business
    Table 40. Chemours Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 41. Chemours Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Zhejiang Yongtai Technology Corporate Information, Head Office, and Major Competitors
    Table 43. Zhejiang Yongtai Technology Major Business
    Table 44. Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 45. Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Shenzhen Capchem Technology Corporate Information, Head Office, and Major Competitors
    Table 47. Shenzhen Capchem Technology Major Business
    Table 48. Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 49. Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Zhejiang Zhongxin Fluoride Materials Corporate Information, Head Office, and Major Competitors
    Table 51. Zhejiang Zhongxin Fluoride Materials Major Business
    Table 52. Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 53. Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. Jiangsu Feiyu Technology Corporate Information, Head Office, and Major Competitors
    Table 55. Jiangsu Feiyu Technology Major Business
    Table 56. Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 57. Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. Shanghai Sinofluoro Corporate Information, Head Office, and Major Competitors
    Table 59. Shanghai Sinofluoro Major Business
    Table 60. Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 61. Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 62. Shanghai Aqbiopharma Corporate Information, Head Office, and Major Competitors
    Table 63. Shanghai Aqbiopharma Major Business
    Table 64. Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 65. Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 66. Hangzhou Fluoro Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 67. Hangzhou Fluoro Pharmaceutical Major Business
    Table 68. Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 69. Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 70. Zhejiang Dayang Biotech Corporate Information, Head Office, and Major Competitors
    Table 71. Zhejiang Dayang Biotech Major Business
    Table 72. Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 73. Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 74. Shandong Feiyuan Group Corporate Information, Head Office, and Major Competitors
    Table 75. Shandong Feiyuan Group Major Business
    Table 76. Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Product and Solutions
    Table 77. Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 78. Global Fluorinated Pharmaceutical Intermediates Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 79. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 80. Breakdown of Fluorinated Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 81. Fluorinated Pharmaceutical Intermediates Players Head Office, Products and Services Provided
    Table 82. Fluorinated Pharmaceutical Intermediates Mergers & Acquisitions in the Past Five Years
    Table 83. Fluorinated Pharmaceutical Intermediates New Entrants and Expansion Plans
    Table 84. Global Fluorinated Pharmaceutical Intermediates Revenue (USD Million) by Type (2017-2022)
    Table 85. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Type (2017-2022)
    Table 86. Global Fluorinated Pharmaceutical Intermediates Revenue Forecast by Type (2023-2028)
    Table 87. Global Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2022)
    Table 88. Global Fluorinated Pharmaceutical Intermediates Revenue Forecast by Application (2023-2028)
    Table 89. North America Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2022) & (USD Million)
    Table 90. North America Fluorinated Pharmaceutical Intermediates Revenue by Type (2023-2028) & (USD Million)
    Table 91. North America Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2022) & (USD Million)
    Table 92. North America Fluorinated Pharmaceutical Intermediates Revenue by Application (2023-2028) & (USD Million)
    Table 93. North America Fluorinated Pharmaceutical Intermediates Revenue by Country (2017-2022) & (USD Million)
    Table 94. North America Fluorinated Pharmaceutical Intermediates Revenue by Country (2023-2028) & (USD Million)
    Table 95. Europe Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2022) & (USD Million)
    Table 96. Europe Fluorinated Pharmaceutical Intermediates Revenue by Type (2023-2028) & (USD Million)
    Table 97. Europe Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2022) & (USD Million)
    Table 98. Europe Fluorinated Pharmaceutical Intermediates Revenue by Application (2023-2028) & (USD Million)
    Table 99. Europe Fluorinated Pharmaceutical Intermediates Revenue by Country (2017-2022) & (USD Million)
    Table 100. Europe Fluorinated Pharmaceutical Intermediates Revenue by Country (2023-2028) & (USD Million)
    Table 101. Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2022) & (USD Million)
    Table 102. Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue by Type (2023-2028) & (USD Million)
    Table 103. Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2022) & (USD Million)
    Table 104. Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue by Application (2023-2028) & (USD Million)
    Table 105. Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue by Region (2017-2022) & (USD Million)
    Table 106. Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue by Region (2023-2028) & (USD Million)
    Table 107. South America Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2022) & (USD Million)
    Table 108. South America Fluorinated Pharmaceutical Intermediates Revenue by Type (2023-2028) & (USD Million)
    Table 109. South America Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2022) & (USD Million)
    Table 110. South America Fluorinated Pharmaceutical Intermediates Revenue by Application (2023-2028) & (USD Million)
    Table 111. South America Fluorinated Pharmaceutical Intermediates Revenue by Country (2017-2022) & (USD Million)
    Table 112. South America Fluorinated Pharmaceutical Intermediates Revenue by Country (2023-2028) & (USD Million)
    Table 113. Middle East & Africa Fluorinated Pharmaceutical Intermediates Revenue by Type (2017-2022) & (USD Million)
    Table 114. Middle East & Africa Fluorinated Pharmaceutical Intermediates Revenue by Type (2023-2028) & (USD Million)
    Table 115. Middle East & Africa Fluorinated Pharmaceutical Intermediates Revenue by Application (2017-2022) & (USD Million)
    Table 116. Middle East & Africa Fluorinated Pharmaceutical Intermediates Revenue by Application (2023-2028) & (USD Million)
    Table 117. Middle East & Africa Fluorinated Pharmaceutical Intermediates Revenue by Country (2017-2022) & (USD Million)
    Table 118. Middle East & Africa Fluorinated Pharmaceutical Intermediates Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Fluorinated Pharmaceutical Intermediates Picture
    Figure 2. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type in 2021
    Figure 3. Aromatic Fluoride
    Figure 4. Aliphatic Fluoride
    Figure 5. Fluorinated Pharmaceutical Intermediates Revenue Market Share by Application in 2021
    Figure 6. Antiviral Drug Picture
    Figure 7. Anti-infectives Drug Picture
    Figure 8. Antirheumatic Drug Picture
    Figure 9. Antibacterial Drug Picture
    Figure 10. Others Picture
    Figure 11. Global Fluorinated Pharmaceutical Intermediates Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 12. Global Fluorinated Pharmaceutical Intermediates Revenue and Forecast (2017-2028) & (USD Million)
    Figure 13. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Region (2017-2028)
    Figure 14. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Region in 2021
    Figure 15. North America Fluorinated Pharmaceutical Intermediates Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. Europe Fluorinated Pharmaceutical Intermediates Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. South America Fluorinated Pharmaceutical Intermediates Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. Middle East and Africa Fluorinated Pharmaceutical Intermediates Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Fluorinated Pharmaceutical Intermediates Market Drivers
    Figure 21. Fluorinated Pharmaceutical Intermediates Market Restraints
    Figure 22. Fluorinated Pharmaceutical Intermediates Market Trends
    Figure 23. Lonza Recent Developments and Future Plans
    Figure 24. Catalent Recent Developments and Future Plans
    Figure 25. Patheon Recent Developments and Future Plans
    Figure 26. BASF Recent Developments and Future Plans
    Figure 27. Jubilant Recent Developments and Future Plans
    Figure 28. Granules Recent Developments and Future Plans
    Figure 29. Ganesh Recent Developments and Future Plans
    Figure 30. Chemcon Recent Developments and Future Plans
    Figure 31. Chemours Recent Developments and Future Plans
    Figure 32. Zhejiang Yongtai Technology Recent Developments and Future Plans
    Figure 33. Shenzhen Capchem Technology Recent Developments and Future Plans
    Figure 34. Zhejiang Zhongxin Fluoride Materials Recent Developments and Future Plans
    Figure 35. Jiangsu Feiyu Technology Recent Developments and Future Plans
    Figure 36. Shanghai Sinofluoro Recent Developments and Future Plans
    Figure 37. Shanghai Aqbiopharma Recent Developments and Future Plans
    Figure 38. Hangzhou Fluoro Pharmaceutical Recent Developments and Future Plans
    Figure 39. Zhejiang Dayang Biotech Recent Developments and Future Plans
    Figure 40. Shandong Feiyuan Group Recent Developments and Future Plans
    Figure 41. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Players in 2021
    Figure 42. Fluorinated Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 43. Global Top 3 Players Fluorinated Pharmaceutical Intermediates Revenue Market Share in 2021
    Figure 44. Global Top 10 Players Fluorinated Pharmaceutical Intermediates Revenue Market Share in 2021
    Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 46. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Type in 2021
    Figure 47. Global Fluorinated Pharmaceutical Intermediates Market Share Forecast by Type (2023-2028)
    Figure 48. Global Fluorinated Pharmaceutical Intermediates Revenue Share by Application in 2021
    Figure 49. Global Fluorinated Pharmaceutical Intermediates Market Share Forecast by Application (2023-2028)
    Figure 50. North America Fluorinated Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
    Figure 51. North America Fluorinated Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
    Figure 52. North America Fluorinated Pharmaceutical Intermediates Revenue Market Share by Country (2017-2028)
    Figure 53. United States Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Canada Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Mexico Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Europe Fluorinated Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
    Figure 57. Europe Fluorinated Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
    Figure 58. Europe Fluorinated Pharmaceutical Intermediates Revenue Market Share by Country (2017-2028)
    Figure 59. Germany Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. France Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. United Kingdom Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Russia Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Italy Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Asia-Pacific Fluorinated Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
    Figure 65. Asia-Pacific Fluorinated Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
    Figure 66. Asia-Pacific Fluorinated Pharmaceutical Intermediates Revenue Market Share by Region (2017-2028)
    Figure 67. China Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Japan Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. South Korea Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. India Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Southeast Asia Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Australia Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. South America Fluorinated Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
    Figure 74. South America Fluorinated Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
    Figure 75. South America Fluorinated Pharmaceutical Intermediates Revenue Market Share by Country (2017-2028)
    Figure 76. Brazil Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Argentina Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Middle East and Africa Fluorinated Pharmaceutical Intermediates Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Fluorinated Pharmaceutical Intermediates Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Fluorinated Pharmaceutical Intermediates Revenue Market Share by Country (2017-2028)
    Figure 81. Turkey Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 82. Saudi Arabia Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 83. UAE Fluorinated Pharmaceutical Intermediates Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lonza
Catalent
Patheon
BASF
Jubilant
Granules
Ganesh
Chemcon
Chemours
Zhejiang Yongtai Technology
Shenzhen Capchem Technology
Zhejiang Zhongxin Fluoride Materials
Jiangsu Feiyu Technology
Shanghai Sinofluoro
Shanghai Aqbiopharma
Hangzhou Fluoro Pharmaceutical
Zhejiang Dayang Biotech
Shandong Feiyuan Group

Related Reports

Global Fluorinated Pharmaceutical Intermediates Supply, Demand and Key Producers, 2023-2029

Global Fluorinated Pharmaceutical Intermediates Supply, Demand and Key Producers, 2023-2029

date 12 Feb 2023

date Chemical & Material

The global Fluorinated Pharmaceutical Intermediates market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Fluorinated Pharmaceutical Intermediates Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Fluorinated Pharmaceutical Intermediates Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 03 Jan 2023

date Chemical & Material

Fluorine-containing intermediates are chemical raw materials or chemical products used in the process of drug synthesis. Such chemical products can be produced in ordinary chemical plants without a drug production license. Can be used for the synthesis of drugs.

Global Fluorinated Pharmaceutical Intermediates Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Fluorinated Pharmaceutical Intermediates Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Chemical & Material

According to our (Global Info Research) latest study, the global Fluorinated Pharmaceutical Intermediates market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

fluorinated pharmaceutical intermediates

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>